June 17, 2024
Global Canine Influenza Vaccine Market

Advancements in Vaccine Technologies Drive Global Canine Influenza Market

A canine influenza vaccine is used to protect dogs against canine influenza virus. Canine influenza is a highly contagious respiratory disease caused by specific Influenza A viral subtypes that infect canines. The disease can cause coughing, runny nose, fever and loss of appetite in dogs. Vaccination is the primary way to prevent canine influenza. The vaccines available in the market are administered annually and provide protection for 12 months from a single dose. The vaccine technologies have advanced significantly to produce effective and stable canine influenza vaccines.

The Global Canine Influenza Vaccine Market is estimated to be valued at US$ 1,805.7 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Canine Influenza Vaccine market are Zoetis Services LLC, Merck Co., Inc., Covetrus, CSL Limited, Boehringer Ingelheim Animal Health USA Inc., and Elanco.

The key opportunities in the Global Canine Influenza Vaccine Market Size include growing pet population and rising pet healthcare expenditure. The increasing trend of nuclear families and rising awareness about preventive care are fueling demand for canine vaccines.

Advancements in vaccine technologies such as recombinant vaccine production allow development of more effective and stable canine influenza vaccines. Cell culture and nucleic acid-based vaccine technologies are also advancing which can drive market growth over the forecast period.

Market Drivers

The key driver for the global canine influenza vaccine market is rising prevalence of canine influenza among dogs. As the disease is highly contagious, vaccination is recommended for all dogs to curb outbreaks. Growing awareness about canine influenza and availability of newer effective vaccines are further supporting the market growth.

Current Challenges in Global Canine Influenza Vaccine Market

The Global Canine Influenza Vaccine Market Size poses a serious threat to dogs worldwide. While vaccines are available, there are several challenges restricting their efficacy and widespread use. One of the biggest issues is the fast mutation rate of the influenza virus, making it difficult for vaccines to provide protection against emerging strains. Researchers are constantly working to develop updated vaccines that can target a broader range of viral subtypes. Another challenge is the lack of awareness among pet owners regarding the need for regular booster doses. Vaccination compliance tends to be low without sufficient education and outreach programs. Moreover, the costs associated with vaccination put it out of reach for many people with multiple pets. This reduces herd immunity and allows the disease to persist in the Dog population. Overall, overcoming information gaps and reducing production costs will help strengthen prevention through vaccination.

SWOT Analysis

Strength: Vaccines developed by leading manufacturers like Zoetis offer cross-protection against multiple virus lineages.

Weakness: High research and development investments are required to keep pace with viral evolution.

Opportunity: Increasing pet ownership in developing regions opens new market potential.

Threats: Outbreaks can damage public perception and demand for vaccines if not controlled quickly.

Geographical Regions

North America currently accounts for the largest share of the global canine influenza vaccine market, both in terms of value and volume. This is attributed to high pet care expenditures and widespread adoption of annual vaccination protocols in countries like the US and Canada.

The Asia Pacific region is expected to witness the fastest growth over the forecast period. Factors such as growing pet ownership, rising disposable incomes, and improving awareness about canine health will support vaccine uptake in emerging economies of China, India and Southeast Asian nations. Rapid urbanization is facilitating easier access to diagnostic and preventive care services.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it